{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:48:03Z","timestamp":1792000083324,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ypmed.2026.108669","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:05:18Z","timestamp":1790687118000},"page":"108669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations of delta-9-tetrahydrocannabinol quantity and cannabis use frequency with cannabis use disorder among adults who use cannabis in the United States"],"prefix":"10.1016","author":[{"given":"Jacob T.","family":"Borodovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara A.","family":"Struble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Budney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah S.","family":"Hasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2026.108669_bb0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.drugalcdep.2018.11.012","article-title":"Higher average potency across the United States is associated with progression to first cannabis use disorder symptom","volume":"195","author":"Arterberry","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.ypmed.2026.108669_bb0010","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/dar.13281","article-title":"Advancing the science on cannabis concentrates and behavioural health","volume":"40","author":"Bidwell","year":"2021","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.ypmed.2026.108669_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2016.08.081","article-title":"Cannabis use data collected via social media: a methodological comparison","volume":"171","author":"Borodovsky","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.ypmed.2026.108669_bb0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/00952990.2023.2246635","article-title":"Exploring survey methods for measuring consumption quantities of cannabis flower and concentrate products","volume":"49","author":"Borodovsky","year":"2023","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.ypmed.2026.108669_bb0025","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/can.2022.0237","article-title":"Typical hits, grams, or joints: evaluating Cannabis survey measurement strategies for quantifying consumption","volume":"9","author":"Borodovsky","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"issue":"4","key":"10.1016\/j.ypmed.2026.108669_bb0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/add.16700","article-title":"Quantity of delta-9-tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers","volume":"120","author":"Borodovsky","year":"2025","journal-title":"Addiction"},{"key":"10.1016\/j.ypmed.2026.108669_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108271","article-title":"Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems","volume":"217","author":"Callaghan","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.ypmed.2026.108669_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230167","article-title":"Mapping cannabis potency in medical and recreational programs in the United States","volume":"15","author":"Cash","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2026.108669_bb0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.drugpo.2018.03.031","article-title":"Big data on a big new market: insights from Washington state\u2019s legal cannabis market","volume":"57","author":"Caulkins","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.ypmed.2026.108669_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102740","article-title":"Intensity of cannabis use: findings from three online surveys","volume":"79","author":"Caulkins","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.ypmed.2026.108669_bb0055","series-title":"2020 National Survey on Drug Use and Health Public Use File Codebook","author":"Center for Behavioral Health Statistics and Quality","year":"2021"},{"key":"10.1016\/j.ypmed.2026.108669_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2018.07.014","article-title":"Cannabis use and the development of tolerance: a systematic review of human evidence","volume":"93","author":"Colizzi","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.ypmed.2026.108669_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","article-title":"Cannabis use and cannabis use disorder","volume":"7","author":"Connor","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.ypmed.2026.108669_bb0070","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09540260902782752","article-title":"Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence","volume":"21","author":"Cooper","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"issue":"5","key":"10.1016\/j.ypmed.2026.108669_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178194","article-title":"Measuring cannabis consumption: psychometric properties of the daily sessions, frequency, age of onset, and quantity of Cannabis use inventory (DFAQ-CU)","volume":"12","author":"Cuttler","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ypmed.2026.108669_bb0080","first-page":"603","article-title":"A comprehensive review of cannabis potency in the United States in the last decade","volume":"6","author":"ElSohly","year":"2021","journal-title":"Biol. Psychiatry: Cognit. Neurosci. Neuroimag."},{"issue":"7","key":"10.1016\/j.ypmed.2026.108669_bb0085","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/add.14842","article-title":"\u201cStandard THC units\u201d: a proposal to standardize dose across all cannabis products and methods of administration","volume":"115","author":"Freeman","year":"2020","journal-title":"Addiction"},{"issue":"15","key":"10.1016\/j.ypmed.2026.108669_bb0090","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1017\/S0033291715001178","article-title":"Examining the profile of high-potency cannabis and its association with severity of cannabis dependence","volume":"45","author":"Freeman","year":"2015","journal-title":"Psychol. Med."},{"issue":"10","key":"10.1016\/j.ypmed.2026.108669_bb0095","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/add.12634","article-title":"Just say \u201cknow\u201d: how do cannabinoid concentrations influence users\u2019 estimates of cannabis potency and the amount they roll in joints?","volume":"109","author":"Freeman","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.ypmed.2026.108669_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugalcdep.2014.11.026","article-title":"The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample","volume":"148","author":"Grant","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.ypmed.2026.108669_bb0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/acer.13940","article-title":"Heterogeneous dose\u2013response analyses of alcohol abuse and dependence","volume":"43","author":"Gruenewald","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.ypmed.2026.108669_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102698","article-title":"Evaluating the impacts of cannabis legalization: the international Cannabis policy study","volume":"77","author":"Hammond","year":"2020","journal-title":"Int. J. Drug Policy"},{"issue":"8","key":"10.1016\/j.ypmed.2026.108669_bb0115","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ypmed.2026.108669_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2026.113028","article-title":"Test-retest reliability of mgTHC consumption in the self-administered Cannabis Exposure Index (CEI)","volume":"279","author":"Hasin","year":"2026","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.ypmed.2026.108669_bb0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/can.2017.0024","article-title":"Anatomy of a joint: comparing self-reported and actual dose of cannabis and tobacco in a joint, and how these are influenced by controlled acute administration","volume":"2","author":"Hindocha","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"issue":"10","key":"10.1016\/j.ypmed.2026.108669_bb0130","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/jamapsychiatry.2020.1035","article-title":"Association of high-potency Cannabis use with mental health and substance use in adolescence","volume":"77","author":"Hines","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.ypmed.2026.108669_bb0135","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"issue":"3","key":"10.1016\/j.ypmed.2026.108669_bb0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.drugalcdep.2011.09.007","article-title":"Quantifying cannabis use with the Timeline Followback approach: a psychometric evaluation","volume":"121","author":"Norberg","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.ypmed.2026.108669_bb0145","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S2215-0366(22)00161-4","article-title":"Association of cannabis potency with mental ill health and addiction: a systematic review","volume":"9","author":"Petrilli","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"10.1016\/j.ypmed.2026.108669_bb0150","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/add.12226","article-title":"Validation of self-reported cannabis dose and potency: an ecological study","volume":"108","author":"van der Pol","year":"2013","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.ypmed.2026.108669_bb0155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1037\/adb0000370","article-title":"Quantifying cannabis: a field study of marijuana quantity estimation","volume":"32","author":"Prince","year":"2018","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.ypmed.2026.108669_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109582","article-title":"Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: a systematic review and meta-analysis","volume":"238","author":"Robinson","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2026.108669_bb0165","author":"SAMHSA"},{"key":"10.1016\/j.ypmed.2026.108669_bb0170","author":"SAMHSA"},{"issue":"4","key":"10.1016\/j.ypmed.2026.108669_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282396","article-title":"Uncomfortably high: testing reveals inflated THC potency on retail cannabis labels","volume":"18","author":"Schwabe","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2026.108669_bb0180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jpsychires.2023.05.048","article-title":"Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use","volume":"163","author":"Shmulewitz","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.ypmed.2026.108669_bb0185","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/add.13886","article-title":"Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state","volume":"112","author":"Smart","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.ypmed.2026.108669_bb0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.copsyc.2019.04.002","article-title":"Changing landscape of cannabis: novel products, formulations, and methods of administration","volume":"30","author":"Spindle","year":"2019","journal-title":"Curr. Opin. Psychol."},{"issue":"2","key":"10.1016\/j.ypmed.2026.108669_bb0195","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1360-0443.2010.03139.x","article-title":"The \u201cgrass ceiling\u201d: limitations in the literature hinder our understanding of cannabis use and its consequences","volume":"106","author":"Temple","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.ypmed.2026.108669_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2017.09.035","article-title":"Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: evidence from a clinical trial","volume":"182","author":"Tomko","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2026.108669_bb0205","article-title":"Evaluating cannabis exposure in survey items: insights, strategies, and remaining challenges identified from cognitive interviewing","volume":"7","author":"Walsh","year":"2023","journal-title":"Drug Alcohol Depend Rep."},{"issue":"12","key":"10.1016\/j.ypmed.2026.108669_bb0210","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2025.2508","article-title":"Reductions in World Health Organization risk drinking levels as a primary efficacy end point for alcohol clinical trials: a review","volume":"82","author":"Witkiewitz","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.ypmed.2026.108669_bb0215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/16066359.2011.569101","article-title":"A \u2018standard joint\u2019? The role of quantity in predicting cannabis-related problems","volume":"20","author":"Zeisser","year":"2012","journal-title":"Addict. Res. Theory"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743526001751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743526001751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:44:03Z","timestamp":1791441843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743526001751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"alternative-id":["S0091743526001751"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2026.108669","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of delta-9-tetrahydrocannabinol quantity and cannabis use frequency with cannabis use disorder among adults who use cannabis in the United States","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2026.108669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108669"}}